Sponsor

Minervax ApS

Denmark Nordre Fasanvej 215, 2000 Frederiksberg, Denmark

About the sponsor

Minervax ApS focuses on clinical research in the prevention of Group B streptococcal infection, with studies centered on immunisation strategies for healthy women and pregnant women.

GBS vaccine development
Maternal immunisation
Infection prevention

The sponsor’s trials examine immune protection against GBS and the durability of antibody responses relevant to maternal and neonatal protection.

About Specializations

Minervax ApS runs clinical trials in conditions such as Group B streptococcus neonatal sepsis, among others.

Group B streptococcus neonatal sepsis

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

3 clinical trials

Group B streptococcus neonatal sepsis

Not yet recruiting

Investigational

Safety and Immune Response of GBS‑NN/NN2 Vaccine in Pregnant Women and Their Infants to Prevent Group B Streptococcus Infection

Investigational

Belgium

Participants:0–17 years · 18–64 years · Healthy volunteers
Sponsor:Minervax ApS

Contact Research Centre

Group B streptococcus neonatal sepsis

Not yet recruiting

Registered drug

Study on the Safety and Immune Response of GBS-NN/NN2 and Tdap Vaccines in Preventing Group B Strep Infection in Healthy Women Aged 18-49

Registered drug

Belgium

Participants:18–64 years · Healthy volunteers
Substances:Diphtheria Toxoid Adsorbed On Aluminium Hydroxide, Hydrated And Aluminium Phosphate
Sponsor:Minervax ApS